Targeting IDH Mutated Glioma: A Decade ’s Journey from Bench to Bedside. Targeting IDH Mutated Glioma: A Decade ’s Journey from Bench to Bedside.

Prof Tim Cloughesy reviews the key early development milestones that lead to the evaluation of Vorasidenib in the INDIGO trial.Medscape Medical Affairs

Source: Medscape Today Headlines - January 8, 2024 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news